Archive for the ‘elsevier’ Category
Last week, we reported that PLoS ONE was retracting three papers by the research group because “there are no data available underlying this study and thus…the published results are fabricated.” Now, according to The Hindu, four more papers are being retracted:
Read the rest of this entry »
The article, “Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study,” purported to show that: Read the rest of this entry »
The South African Journal of Botany has retracted a 2012 paper that claimed a variety of herbal extracts have antioxidant and anti-fungal properties, due to errors in “at least” one figure.
Here’s the notice for “Contribution of herbal principles towards cytoprotective, antioxidant and anti-Rhizopus activities:”
The authors of a paper showing a link between immune response and depression requested a retraction after they realized they’d merged two spreadsheets with mismatching ID codes.
Here’s the notice for “Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years,” retracted in February 2014:
In our coverage Tuesday of the republication of the controversial retracted study of GMOs and rats by Gilles Seralini and colleagues, we wrote this about a strange passage in an editor’s note on the paper:
The republished study was peer-reviewed, according to the press materials, and Seralini confirmed that it was in an email to Retraction Watch. But we were curious what “any kind of appraisal of the paper’s content should not be connoted” meant. We asked Seralini and the editor of Environmental Sciences Europe, Henner Hollert, but neither responded.
A Boston doctor indicted on charges of Medicare fraud in 2007 has had a paper relating to the case retracted this month.
Abdul Razzaque Ahmed was considered something of a miracle worker by his patients, treating two rare and disfiguring skin conditions called pemphigoid and pemphigus vulgaris. He used more powerful medicines than the typical course of treatment, including a drug normally used to treat cancer.
The initial indictment stated that Ahmed mixed blood samples to falsely show a “dual diagnosis” of both diseases, and prove to Medicare that they required the more rigorous (and expensive) treatment. It also alleged that he profited massively from the government pay-outs. He was convicted of obstruction in 2007; the other charges were dropped when he agreed to forfeit assets worth $2.9 million.
Now, a 2001 paper by Ahmed, which claimed fifteen patients had a dual diagnosis, has been retracted because the samples were all mixed. Here is the retraction notice from Clinical Immunology: Read the rest of this entry »
A group of authors in China has lost their 2011 paper in Bioresource Technology on pig poop because the journal detected a whiff of the familiar in a previously published article by other researchers in the same journal (a major tsk tsk and, well, oops).
The article, “Feasibility of biogas production from anaerobic co-digestion of herbal-extraction residues with swine manure,” came from a team at Nanchang University. Except, well, not really, as we’ll see. According to its abstract:
Read the rest of this entry »
Here’s the notice for “The role of deliberate and experiential learning in developing capabilities: Insights from technology licensing,” a paper originally published in 2012 in the Journal of Engineering and Technology Management: Read the rest of this entry »